Catalyst Wire Dossier Catalyst Wire Dossier

Rotavin-M1

Rotavirus vaccine, live attenuated · National Institute of Hygiene and Epidemiology
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Rotavin-M1, covering 2012-01-02 to 2016-07-04. Get the full timeline:

Most recent: Clinical Trial Update: A Dose-escalating Study to Evaluate the Immunogenicity and Safety of Rotavin-M1 Vaccine in Healthy Infants [Phase 2]

See pricing